Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1622 1624
This examiner grants 82% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17949188 | 1-[2-(2,4-DIMETHYLPHENYLSULFANYL)-PHENYL]PIPERAZINE AS A COMPOUND WITH COMBINED SEROTONIN REUPTAKE, 5-HT3 AND 5-HT1A ACTIVITY FOR THE TREATMENT OF COGNITIVE IMPAIRMENT | Non-Final OA | H. Lundbeck A/S |
| 18282083 | BIARYL AMIDE AND HETEROARYL AMIDES FOR TREATMENT OF CANDIDA ALBICANS INFECTION | Non-Final OA | Board of Regents, The University of Texas System |
| 18549158 | Treatment of Breast Cancer with Amcenestrant and Palbociclib | Non-Final OA | Pfizer Inc. |
| 18576983 | USE OF LACTIC ACID IN POSTMENOPAUSAL WOMEN | Non-Final OA | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL |
| 18488248 | STEVIA COMPOSITION | Non-Final OA | PURECIRCLE SDN BHD |
| 18579114 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK WITH DIMINISHED IMID ACTIVITY | Non-Final OA | NURIX THERAPEUTICS, INC. |
| 18259532 | REAGENT AND METHOD FOR TREATING SKIN DISEASES OR CONDITIONS ASSOCIATED WITH ANTI-TUMOR AGENT | Non-Final OA | ONQUALITY PHARMACEUTICALS CHINA LTD. |
| 18558166 | PROCESS FOR THE PREPARATION OF ANTIBACTERIAL COMPOUNDS | Non-Final OA | DISCUVA LIMITED |
| 18288195 | A SOLID STATE FORM OF TAFAMIDIS AND A PROCESS FOR ITS PREPARATION | Non-Final OA | Quimica Sintetica, S.A. |
| 18273011 | IMIDAZOLOPYRIDAZINE OR PYRAZOLOPYRIMIDINE COMPOUNDS AND COMPOSITIONS | Non-Final OA | Anrui Biomedical Technology (Guangzhou) Co., Ltd. |
| 18020761 | METHODS OF TREATING GOUT | Non-Final OA | Horizon Therapeutics USA, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy